The Lobbying Register, read carefully Epicycle

Returns

Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.

Clear all

Showing returns filed by MSD .

Filed returns
38
match these filters
Matching filed returns per period 0 1 2 3 5 Sep–Dec 2016: 2 filed returns May–Aug 2017: 2 filed returns Sep–Dec 2017: 1 filed returns Jan–Apr 2018: 1 filed returns Sep–Dec 2018: 2 filed returns Jan–Apr 2019: 3 filed returns May–Aug 2019: 3 filed returns Sep–Dec 2020: 3 filed returns Jan–Apr 2021: 1 filed returns May–Aug 2021: 1 filed returns Sep–Dec 2021: 2 filed returns Jan–Apr 2022: 1 filed returns Sep–Dec 2022: 2 filed returns Jan–Apr 2023: 1 filed returns May–Aug 2023: 2 filed returns Sep–Dec 2023: 2 filed returns May–Aug 2024: 1 filed returns Sep–Dec 2024: 1 filed returns May–Aug 2025: 2 filed returns Jan–Apr 2026: 3 filed returns May–Aug 2026: 2 filed returns 2018 2019 2021 2022 2023 2026
Filed returns per four-month period Click a column to list its returns.
PeriodRegistrantPolicy areaSubject, as filedOfficials namedLink
May–Aug 2026 MSD Health Oncology nursing workforce and cancer care service policy (Public policy or programme) 1 On lobbying.ie
May–Aug 2026 MSD Health Pulmonary Arterial Hypertension (PAH) services (Public policy or programme) 8 On lobbying.ie
Jan–Apr 2026 MSD Health National Cancer Strategy & future of cancer care in Ireland (Public policy or programme) 4 On lobbying.ie
Jan–Apr 2026 MSD Health EU Safe Hearts Plan (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2026 MSD Health Cancer Outcomes in Ireland (Public policy or programme) 10 On lobbying.ie
May–Aug 2025 MSD Health Health and industry policy (Public policy or programme) 3 On lobbying.ie
May–Aug 2025 MSD Health Advocacy on Pulmonary Arterial Hypertension Policy in Ireland (Public policy or programme) 10 On lobbying.ie
Sep–Dec 2024 MSD Health Health Policy Development for New Programme for Government (Public policy or programme) 46 On lobbying.ie
May–Aug 2024 MSD Health European policy on innovative pharmaceutical medicine (Public policy or programme) 19 On lobbying.ie
Sep–Dec 2023 MSD Health Access to Innovative Medicines (Public policy or programme) 1 On lobbying.ie
Sep–Dec 2023 MSD Health To highlight problems in Ireland faced by patients with TNBC and policy areas that need focus. (Public policy or programme) 2 On lobbying.ie
May–Aug 2023 MSD Health Access to innovative cancer medicines (Public policy or programme) 7 On lobbying.ie
May–Aug 2023 MSD Health Early detection and treatment of cancer (Public policy or programme) 5 On lobbying.ie
Jan–Apr 2023 MSD Health Early detection and treatment of cancer (Public policy or programme) 11 On lobbying.ie
Sep–Dec 2022 MSD Economic Development and Industry Positioning Ireland in the Global Biopharmaceutical Industry (Public policy or programme) 7 On lobbying.ie
Sep–Dec 2022 MSD Health Immunisation Policies (Public policy or programme) 4 On lobbying.ie
Jan–Apr 2022 MSD Health Immunisation Policies (Public policy or programme) 7 On lobbying.ie
Sep–Dec 2021 MSD Health Immunisation Policies (Public policy or programme) 26 On lobbying.ie
Sep–Dec 2021 MSD Health Cancer Care in a post-pandemic COVID-19 era (Public policy or programme) 15 On lobbying.ie
May–Aug 2021 MSD Health Cancer Care in a post-pandemic COVID-19 era (Public policy or programme) 18 On lobbying.ie
Jan–Apr 2021 MSD Health Oncology Policy (Public policy or programme) 9 On lobbying.ie
Sep–Dec 2020 MSD Health Policy Priorities in a post-pandemic COVID-19 era (Public policy or programme) 26 On lobbying.ie
Sep–Dec 2020 MSD Health Oncology Policy (Public policy or programme) 34 On lobbying.ie
Sep–Dec 2020 MSD Health Immunisation Policies (Public policy or programme) 5 On lobbying.ie
May–Aug 2019 MSD Health Immunisation Policies (Public policy or programme) 46 On lobbying.ie
May–Aug 2019 MSD Health Accessing Innovative Medicines (Public policy or programme) 4 On lobbying.ie
May–Aug 2019 MSD Economic Development and Industry Development of the Pharmaceutical industry in Ireland (Public policy or programme) 42 On lobbying.ie
Jan–Apr 2019 MSD Health Immunisation Policies (Public policy or programme) 4 On lobbying.ie
Jan–Apr 2019 MSD Health Accessing Innovative Medicines (Public policy or programme) 7 On lobbying.ie
Jan–Apr 2019 MSD Economic Development and Industry Development of the Pharmaceutical industry in Ireland (Public policy or programme) 91 On lobbying.ie
Sep–Dec 2018 MSD Health Lung Cancer Policy (Public policy or programme) 54 On lobbying.ie
Sep–Dec 2018 MSD Health Access to Innovative Medicines (Public policy or programme) 14 On lobbying.ie
Jan–Apr 2018 MSD Economic Development and Industry Biopharma Investment and Development (Public policy or programme) 29 On lobbying.ie
Sep–Dec 2017 MSD Health Access to innovation in Oncology (Public policy or programme) 6 On lobbying.ie
May–Aug 2017 MSD Health Oncology Policy (Public policy or programme) 19 On lobbying.ie
May–Aug 2017 MSD Health Immunisation Programmes (Public policy or programme) 19 On lobbying.ie
Sep–Dec 2016 MSD Health Immunisation Programmes (Public policy or programme) 6 On lobbying.ie
Sep–Dec 2016 MSD Health Future Healthcare Policy (Public policy or programme) 25 On lobbying.ie

Policy areas in these returns

Public policy areaFiled returnsShareRelative to the largest
Health 34 89.5%
Economic Development and Industry 4 10.5%